214 related articles for article (PubMed ID: 29192411)
1. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study.
Temur M; Calan M; Akşit M; Yılmaz Ö; Çift T; Akselim B; Dinçgez Çakmak B; Üstünyurt E
Ginekol Pol; 2017; 88(10):517-522. PubMed ID: 29192411
[TBL] [Abstract][Full Text] [Related]
2. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of neuregulin 4 (NRG4) in gestational diabetes mellitus.
Kurek Eken M; Yayla Abide C; Sahin Ersoy G; Altun Ensari T; Pekin O; Cevik O
Gynecol Endocrinol; 2018 Jul; 34(7):605-608. PubMed ID: 29282998
[TBL] [Abstract][Full Text] [Related]
6. Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome.
Cao S; Hu Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34427289
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
8. Circulating neuregulin-1 levels in polycystic ovary syndrome.
Arpacı H
J Obstet Gynaecol; 2019 May; 39(4):504-509. PubMed ID: 30634887
[TBL] [Abstract][Full Text] [Related]
9. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
10. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
13. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
14. The relationship of urocortin-2 with insulin resistance patients having PCOS.
Temur M; Yılmaz Ö; Aksun S; Calan M; Özün Özbay P; Kumbasar S; Sever E
Gynecol Endocrinol; 2017 Feb; 33(2):124-127. PubMed ID: 27841039
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study.
Cai C; Lin M; Xu Y; Li X; Yang S; Zhang H
BMC Med; 2016 Oct; 14(1):165. PubMed ID: 27772531
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome.
Temur M; Yilmaz Ö; Aksun S; Özün Özbay P; Calan M; Küme T; Karakulak M; Korkmaz HA
Gynecol Endocrinol; 2016; 32(3):218-22. PubMed ID: 26488073
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of xenopsin-related peptide-1 are associated with polycystic ovary syndrome.
Temur M; Özün Özbay P; Aksun S; Yilmaz Ö; Çift T; Üstünel S; Calan M
Arch Gynecol Obstet; 2017 Oct; 296(4):841-846. PubMed ID: 28831586
[TBL] [Abstract][Full Text] [Related]
19. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.
Shen SH; Shen SY; Liou TH; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():66-71. PubMed ID: 26177495
[TBL] [Abstract][Full Text] [Related]
20. Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study.
Jeelani H; Ganie MA; Masood A; Amin S; Kawa IA; Fatima Q; Manzoor S; Parvez T; Naikoo NA; Rashid F
Diabetes Metab Syndr; 2019; 13(5):2907-2915. PubMed ID: 31425955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
